رجوع
نطاق اليوم
KWD 14.00
KWD 14.00
نطاق 52 أسبوعًا
KWD 0.78
KWD 25.00
حجم التداول
5,403,471
متوسط 50 يوم / 200 يوم
KWD 12.84
/
KWD 6.40
الإغلاق السابق
KWD 14.00
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -7.4 | 0.2 |
| P/B | 4.0 | 3.0 |
| ROE % | -54.3 | 3.6 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 9.9 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 14.00
+0.0%
ربحية السهم المستقبلية
-KWD 1.77
الإيرادات المقدّرة
13.10M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
KWD 0.09
KWD 0.09 – KWD 0.09
|
394.49M | 1 |
| FY2028 |
-KWD 0.55
-KWD 1.32 – KWD 0.97
|
267.26M | 5 |
| FY2027 |
-KWD 1.60
-KWD 2.27 – -KWD 1.14
|
30.57M | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-06 | -KWD 0.45 | -KWD 0.32 | +28.9% |
| 2025-08-07 | -KWD 0.45 | -KWD 0.38 | +15.6% |
| 2025-05-08 | -KWD 0.48 | -KWD 0.39 | +18.8% |
| 2025-02-27 | -KWD 0.54 | -KWD 0.41 | +24.1% |
| 2024-11-07 | -KWD 0.48 | -KWD 0.50 | -4.2% |
| 2024-08-08 | -KWD 0.57 | -KWD 0.45 | +21.1% |
| 2024-05-09 | -KWD 0.67 | -KWD 0.62 | +7.5% |
| 2024-02-27 | -KWD 0.78 | -KWD 0.79 | -1.3% |
Dividend History
Yield
0.00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Debt/Equity of 0.04 — conservative balance sheet
Negative free cash flow of -131.11M
PEG of 0.03 suggests growth is underpriced
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-54.27%
ROIC-42.04%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.04
Current Ratio17.97
Interest Coverage0.00
التقييم
P/E Ratio
-7.43
Forward P/EN/A
P/B Ratio3.95
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -135.12M |
| ROE | -54.27% | ROA | -48.86% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -131.11M |
| ROIC | -42.04% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.04 | Current Ratio | 17.97 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7.43 | Forward P/E | N/A |
| P/B Ratio | 3.95 | P/S Ratio | N/A |
| PEG Ratio | 0.03 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -13.05% | ||
| Market Cap | 1.00B | Enterprise Value | 988.04M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -135.12M | -192.96M | -108.43M | -83.75M | -28.17M |
| EPS (Diluted) | -1.97 | -3.30 | -2.06 | -1.69 | -0.56 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -148.45M | -207.99M | -113.14M | -67.15M | -7.05M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 276.56M | 277.69M | 371.40M | 291.48M | 245,000.0 |
| Total Liabilities | 22.52M | 33.77M | 17.51M | 12.28M | 30.90M |
| Shareholders' Equity | 254.05M | 243.92M | 353.90M | 279.20M | -30.65M |
| Total Debt | 10.79M | 12.51M | 1.56M | 0.0 | 12.65M |
| Cash & Equivalents | 27.26M | 51.58M | 64.82M | 70.79M | 244,000.0 |
| Current Assets | 229.63M | 264.35M | 330.69M | 263.02M | 245,000.0 |
| Current Liabilities | 12.78M | 22.27M | 16.36M | 12.28M | 1.40M |